Aspen Aerogels
ASPN
51 hedge funds and large institutions have $76.5M invested in Aspen Aerogels in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 7
13% more funds holding
Funds holding: 45 → 51 (+6)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.13% less ownership
Funds ownership: 74.66% → 74.52% (-0.13%)
2% less capital invested
Capital invested by funds: $78M → $76.5M (-$1.55M)
Top Buyers
Top Sellers
ASPN Hedge Fund Activity: Q3 2017 in Review
51 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Aspen Aerogels (ASPN) for Q3 2017, worth a combined $76.5M — down 2% from $78M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ASPN positions and 2 closed out — a net gain of 6 holders — while 14 added to existing stakes and 7 trimmed.
The largest buyer was Quantum Capital Management (California), adding an estimated $920K. The largest seller was Wellington Management Group, exiting entirely with an estimated $4.08M sold.
- 51 institutional investors held Aspen Aerogels (ASPN) as of Q3 2017, up from 45 in Q2 2017.
- Funds reported $76.5M of Aspen Aerogels stock for Q3 2017, down 2% quarter-over-quarter.
- 8 funds opened new Aspen Aerogels positions in Q3 2017 and 2 closed out, a net change of +6 holders.
- The largest Aspen Aerogels buyer in Q3 2017 was Quantum Capital Management (California), an estimated $920K added.
- The largest Aspen Aerogels seller in Q3 2017 was Wellington Management Group, an estimated $4.08M sold.
Based on aggregated 13F filings for Q3 2017.